Among the companies with shares expected to actively trade in
Monday's session are McDonald's Corp. (MCD), Apricus Biosciences
Inc. (APRI) and Dynavax Technologies Corp. (DVAX).
McDonald's global same-store sales rose a stronger-than-expected
2.6% in May as the world's largest fast-food chain's expanded menu
helped attract customers. Shares rose 1.8% to $100.05
premarket.
Apricus Biosciences, which focuses on developing drugs in the
area of sexual health, said its Vitaros drug for hard to treat
cases of erectile dysfunction was approved by European regulators.
Shares rose 11% to $2.84 premarket.
Dynavax Technologies said it was told by the U.S. Food and Drug
Administration its Biologic License Application for its
investigational adult hepatitis B vaccine needs more work. Shares
fell 25% to $1.86 premarket.
Titan International Inc. (TWI) said Friday it is experiencing a
"bump in the road" as original-equipment manufacturers in the farm
and construction industries, as well as mining companies, have
dropped millions of dollars in tires into the aftermarket over the
past couple of months. The company said it plans to lower the
full-year guidance it gave in December, but first needs to find out
approximately how much mining companies will be lowering their
inventories. Shares fell 5.1% to $19.66 premarket amid at least two
downgrades from analysts.
Watchlist:
Aveo Pharmaceuticals Inc. (AVEO) said the U.S. Food and Drug
Administration rejected its new drug application for tivozanib as a
treatment for advanced renal cell carcinoma, citing inconsistent
survival results.
B&G Foods Inc (BGS) has agreed to acquire Robert's American
Gourmet Food LLC from VMG Partners, Driven Capital Management,
founder Robert Ehrlich and other parties for about $195 million in
cash, a move that bolsters the packaged-food maker's snack
business.
Gilead Sciences Inc. (GILD) said its experimental oral
hepatitis-C treatment, sofosbuvir, has received priority-review
status from the U.S. Food and Drug Administration.
Business-information provider IHS Inc. (IHS) plans to acquire
R.L. Polk & Co. (POLL), owner of the used-car shopping toll
Carfax, in a $1.4 billion cash-and-stock deal.
Stemline Therapeutics Inc.'s (STML) investigational treatment
for a rare and aggressive hematologic malignancy was granted orphan
status by the U.S. Food and Drug Administration.
Stillwater Mining Co. (SWC) said its Chief Executive Frank
McAllister is retiring, and will be replaced in the interim by
Terrell I. Ackerman.
Write to Anna Prior at anna.prior@dowjones.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires